Prolonged effect of 5-fluorouracil and its derivatives on apoptosis induction and mitotic inhibition in the intestinal epithelium of male BDF1 mice

Journal of Toxicologic Pathology

Volumn 11, Issue 3, 1998, Pages 177-182

  Inomata, Akira ^a,b,c   Horii, Ikuo ^a   Suzuki, Katsushi ^b  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^c NRRC   (Japan)

Author keywords

5 fluorouracil; Apoptotic Index; BDF1 mice; Intestinal epithelium; Mitotic Index

Indexed keywords

EID: 54649084149     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.11.177     Document Type: Article

References (19)

1. Der S, Jonek JJ, and Konecki. The effect of 5-fluorouracil on the mitotic cycle and DNA synthesis in the epithelium of mouse small intestine. Folia Histochem et Cytochem 1975; 13: 21-36.
2. Lowe S, Ruley HE, Jackes T, and Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-67.
3. Pickard M, Dive C, and Kinsella AR. Differences in resistance to 5-fluorouracil as a function of cell-cycle delay and not apoptosis. Br J Cancer 1995; 72: 1389-96.
4. Curtin NJ, Harris AL, and Aherne GW. Mechanism of cell death following thymidine synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res 1991; 51: 2346-52.
5. Potten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer and Metastasis Reviews 1992; 11: 179-95.
6. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-31.
7. Ijiri K, and Potten CS. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 1983; 47: 175-85.
8. Ijiri K, and Potten CS. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 1987; 55: 113-23.
9. Ijiri K. Apoptosis (cell death) induced in mouse bowel by 1, 2-dimethylhydrazine, methylazomethanol acetate, and gammarays. Cancer Res 1989; 49: 6342-6.
10. Ijiri K. Cell death (Apoptosis) in mouse intestine after continuous irradiation with y rays and with β rays from tritiated water. Rad Res. 1989; 118: 1-12.
11. Ohta Y, Sueki K, Kitta K, Takemoto K, Ishitsuka H, and Yagi Y. Comparative studies on the immunosuppressive effect among 5′-deoxy-5-fluorouridine, ftorafur and 5-fluorouracil. Gann 1980; 71: 190-6.
12. Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A, and Maruyama HB. Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Jpn J Cancer Res 1980; 71: 112-23.
13. Ishitsuka H, Miwa M, Ishikawa T, Ura M, Sawada N, Nishida M, Fukase Y, Yamamoto T, Mori K, Arasaki M, Umeda I, and Shimma N. Capecitabine: a orally available fluoropyrimidine with tumor selective activity. Prc Am Assoc Cancer Res 1995; 36: 2426.
14. Ishikawa T, Utoh M, Sawada N, Nishida M, Fukase Y, Sekiguchi F, and Ishitsuka H. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol (in press) 1998.
15. Gavrieli Y, Sherman Y, and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
16. Wyllie AH, Karr JFR, and Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-307.
17. Potten CS. What is an apoptotic index measuring? A commentary. Br J Cancer 1996; 74: 1743-8.
18. Inada T, Ogata A Y, Kubota T, Ozawa I, Hishimura S, Shimizu H, Kotake K, Ikeda T, and Koyama Y. A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer. Surg Today 1993; 23: 687-92.
19. Yoshikawa K, Iwasaki T, Amemiya A, Emoto T, Fujii M, Han N, Itou A, and Tsujimura T. Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases. Jpn J Cancer Chemother 1990; 17: 1333-7.